Zotec Partners (Zotec), one of the country's largest, privately-held, technology-enabled revenue cycle management (RCM) companies for healthcare providers and their patients, today announced first-of-its-kind technology that will deliver an efficient, automated process to patients impacted by COVID-19.
Bimini Health Tech announced today it received FDA 510(k) clearance (K193363) for its novel Dermapose Refresh® Syringe-Based, Fat Transfer Technology. Dermapose Refresh is an all-in-one microfat transfer system intended to make small volume fat transfer quick, safe, and easy.
Vuzix® Corporation, a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, together with Librestream Technologies Inc., a leading provider of augmented reality enterprise solutions, today announced a telehealth support kit that includes Librestream's Onsight remote expert software and the Vuzix M400 Smart Glasses.
HandsFree Health™, provider of WellBe®, a secure, HIPAA compliant, voice-enabled virtual assistant platform, announced a patent-pending technology which allows remote setup of the HandsFree Health platform from anywhere in the U.S. at any time while integrating automatic software updates as well.
Abbott (NYSE: ABT) announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19).
Spectrum Solutions, LLC today announced the FDA Emergency Use Authorization (EUA) approval for the immediate use of saliva in COVID-19 testing exclusively using the Spectrum SDNA-1000 saliva collection device which has been proven to protect and preserve RNA used for the detection of infection.
Khrysos Industries, Inc. owned subsidiary of Youngevity International, Inc., announced today that the company has begun producing hand sanitizer in various sizes including 2 oz., 4 oz., 8 oz., and 1 Gallon Packaging.
Clarify Health, a leader in healthcare analytics, announced today that it launched two new critical applications in response to the needs of customers at the forefront of providing care to the communities impacted by COVID-19.
Nuclein LLC announces plans to expedite the commercialization of its Nuclein™ Hand-Held PCR Test.
The Feinstein Institutes for Medical Research, the research arm of Northwell Health, announced today the enrollment of three clinical trials in the ongoing effort to combat COVID-19, the novel coronavirus.